The future of cancer treatment – combining stem cells and immunotherapy.

The company leads an AU$2.987 million Department of Industry, Innovation and Science Co-operative Research Centre project in partnership with the Hudson Institute of Medical Research, Monash University, Mesoblast Ltd and Cell Therapies Pty Ltd.

Cartherics is:

• Creating a new class of cancer treatments beyond surgery, chemotherapy, biologicals and radiation.
• Supercharging a patient’s own immune system, helping it eliminate cancer.
• Developing accessible ‘off-the-shelf’ immunotherapies to fight aggressive forms of cancers like relapsed ovarian and gastric cancers.

Transforming cancer from a fatal disease to a manageable condition.